Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,661 across all filing types
Latest filing 2021-02-05 Board/Management Inform…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
MOREPEN LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the Un-audited Financial ....
Board/Management Information Classification · 95% confidence The document is a notice of a scheduled Board Meeting to consider and approve the unaudited financial results for a specific quarter and nine months period. It is addressed to stock exchanges and references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which governs disclosures related to board meetings. The document does not contain actual financial data or results but is an announcement of the meeting where such results will be considered. The document length is short (1598 characters), and it serves as an intimation rather than a report or detailed financial disclosure. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related disclosures.
2021-02-05 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content consists of multiple letters from the Registrar and Share Transfer Agent informing the exchanges about the loss of share certificates. There is no financial data, no discussion of financial results, no management commentary, no voting results, no legal proceedings, no capital changes, or other report types. The document is essentially a regulatory notification about share certificate loss, which does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement related to compliance and disclosure obligations. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-02 English
Morepen Laboratories Ltd has informed BSE regarding loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates by shareholders and the request for issuance of duplicate share certificates. It references Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to reporting such events. The content is about notifying the stock exchanges of lost share certificates and related administrative details. There is no financial data, no discussion of financial results, no management commentary, no voting results, no legal proceedings, no capital changes, or other report types. The document is essentially a regulatory notification about share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2021-02-02 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) regarding the issuance of duplicate share certificates. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 39(3), which pertains to share certificate issuance and transfer. The content is about notifying the stock exchanges about the issuance of duplicate share certificates to shareholders, including details of old and new certificate numbers and shareholder names. There is no financial data, earnings information, management discussion, or report attached or referenced as being published. The document is an official regulatory announcement related to share certificates, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure and does not fit other more specific categories like Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS).
2021-01-29 English
Morepen Laboratories Ltd has informed BSE regarding issuance of duplicate share Certificates
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (National Stock Exchange of India Ltd. and BSE Limited) regarding the issuance of duplicate share certificates. It references Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate issuance and transfer. The content is about notifying the stock exchanges about duplicate share certificates issued to shareholders, including details such as folio numbers, old and new certificate numbers, and shareholder names. There is no financial data, earnings information, management discussion, or report attached. The document is an official announcement related to share certificates, which falls under the category of share issue or capital change announcements. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length is about 5,042 characters, which is sufficient to be a full announcement rather than a brief note or a report publication announcement.
2021-01-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the loss of share certificates and the request for issuance of duplicate share certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the stock exchanges about the loss of share certificates and does not contain financial data, earnings, management discussion, or any report. It is a regulatory announcement related to shareholding documentation but not a major shareholding notification or director dealing. It is a regulatory filing informing the exchanges about a procedural matter concerning share certificates. The document length is short (2663 characters) and is a formal notification letter, fitting best under Regulatory Filings (RNS).
2021-01-25 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.